Top Markets
#1 Siacoin Siacoin +35.47%
#2 Official Trump Official Trump +25.00%
#3 EXOD EXOD +22.08%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.57%
#5 MowCat MowCat +17.97%
#6 Melania Meme Melania Meme +17.87%
#7 Pump.fun Pump.fun +17.06%
#8 Unit Pump Unit Pump +17.06%
#9 The Bitcoin Bull The Bitcoin Bull +16.12%
#10 Siren Siren +15.73%
Coin of the day
Siacoin Siacoin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Rang in Aktien #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Aktienkurs
$19.30
Zuletzt synchronisiert: 2023-12-26
Marktkapitalisierung
$72.77M
Veränderung (1 Tag)
6.22%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Aeglea BioTherapeutics, Inc. (AGLE)

Kategorie

Healthcare
P/S-Verhältnis für Aeglea BioTherapeutics, Inc. (AGLE)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Aeglea BioTherapeutics, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Aeglea BioTherapeutics, Inc. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH